NCT05414357View on ClinicalTrials.gov

Impact of Sleep Disturbance on Cognition and Quality of Life in Breast Cancer

NARecruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

March 20, 2023

Primary Completion Date

March 31, 2027

Study Completion Date

September 30, 2027

Conditions
Breast CancerSleepQuality of Life
Interventions
DIAGNOSTIC_TEST

Functional Magnetic Resonance Imaging at rest and in activation with attentional task

"Participants complete 3 successive assessments (T1: baseline, T2: at 6 months, T3: after galvanic vestibular stimulation). Assessments include:~* Functional and Anatomic Magnetic Resonance Imaging at rest and in activation (only at T1 and T2).~* Biological and physiological measurements~* Spatial memory task~* Cognitive battery~* Questionnaires (sleep, quality of life)"

Trial Locations (2)

14000

RECRUITING

Centre François Baclesse, Caen

NOT_YET_RECRUITING

Inserm-Ephe-Unicaen U1077, Caen

All Listed Sponsors
collaborator

UMR_S 1077 Inserm-EPHE-Normandie Université

UNKNOWN

lead

Centre Francois Baclesse

OTHER